247 related articles for article (PubMed ID: 28807926)
1. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
[No Abstract] [Full Text] [Related]
2. Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Res; 2017 Nov; 77(21):6033-6041. PubMed ID: 28935814
[TBL] [Abstract][Full Text] [Related]
3. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS
Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337
[TBL] [Abstract][Full Text] [Related]
4. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis.
Balkrishnan R; Desai RP; Narayan A; Camacho FT; Flausino LE; Chammas R
Cancer Med; 2021 Aug; 10(15):5347-5357. PubMed ID: 34184420
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and outcomes following early-stage breast cancer.
Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
[TBL] [Abstract][Full Text] [Related]
6. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
[TBL] [Abstract][Full Text] [Related]
7. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
8. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.
Chen L; Malone KE; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1423-6. PubMed ID: 26084603
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer.
Lorona NC; Cook LS; Tang MC; Hill DA; Wiggins CL; Li CI
Cancer Causes Control; 2021 Dec; 32(12):1375-1384. PubMed ID: 34347212
[TBL] [Abstract][Full Text] [Related]
10. Frequent antibiotic use and second breast cancer events.
Wirtz HS; Buist DS; Gralow JR; Barlow WE; Gray S; Chubak J; Yu O; Bowles EJ; Fujii M; Boudreau DM
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1588-99. PubMed ID: 23833124
[TBL] [Abstract][Full Text] [Related]
11. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
12. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
Harding BN; Delaney JA; Urban RR; Weiss NS
Gynecol Oncol; 2019 Aug; 154(2):426-431. PubMed ID: 31178150
[TBL] [Abstract][Full Text] [Related]
13. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
[TBL] [Abstract][Full Text] [Related]
14. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.
Ganz PA; Habel LA; Weltzien EK; Caan BJ; Cole SW
Breast Cancer Res Treat; 2011 Sep; 129(2):549-56. PubMed ID: 21479924
[TBL] [Abstract][Full Text] [Related]
15. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Pérez-Gómez B; Lope V; Tusquets I; Alonso MH; Moreno V; Amiano P; Molina de la Torre AJ; Barricarte A; Tardon A; Camacho A; Peiro-Perez R; Marcos-Gragera R; Muñoz M; Michelena-Echeveste MJ; Ortega Valin L; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
PLoS One; 2016; 11(8):e0159672. PubMed ID: 27508297
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer.
van la Parra RFD; Liao K; Smith BD; Yang WT; Leung JWT; Giordano SH; Kuerer HM
JAMA Surg; 2018 Jun; 153(6):559-568. PubMed ID: 29387884
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
18. Risk of second breast cancer events with chronic opioid use in breast cancer survivors.
Boudreau DM; Chen L; Yu O; Bowles EJA; Chubak J
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):740-753. PubMed ID: 30945381
[TBL] [Abstract][Full Text] [Related]
19. Causes of death and relative survival of older women after a breast cancer diagnosis.
Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
[TBL] [Abstract][Full Text] [Related]
20. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
